Coronavirus

Listen to Dr. Wayne Winegarden, PRI senior fellow in business and economics and director of PRI's Center for Medical Economics and Innovation, discuss his new brief "No Solutions, Only Tradeoffs," which explores how the small health benefits generated by state COVID-19 lockdowns were more than offset by huge losses in education and the economy. TheLarsLarsonShow · Dr Wayne Winegarden Did Covid Restrictions Wreck Our Economy For Nothing...

The price of a COVID-19 shot will soon go up. The federal public health emergency ended this month, and the government will stop providing COVID vaccines to all Americans free of charge. Moderna and Pfizer have both signaled that they plan to raise the prices of their shots once the vaccines move to the commercial market. And that's prompted outrage from some of the drug companies' typical foes. Vermont Senator Bernie Sanders castigated Moderna CEO Stéphane Bancel at a recent hearing...

To the old saying about the inevitability of death and taxes, we should add another: another health crisis linked to COVID-19. As of the end of October, the CDC’s official tally of U.S. COVID infections was just under 100 million, but with many positive home test results unreported, the real number is estimated to be several times greater. Infections, while unfortunate and sometimes deadly, do provide immunity to survivors, but only for a limited time. Natural post-infection and vaccine-induced immunity wane...

By Henry Miller and Josh Bloom President Biden’s bout with COVID-19 is illustrative of the debate currently raging about “Paxlovid rebound” — the recurrence of symptoms and of testing positive for SARS-CoV-2 after a seemingly successful five-day treatment course of Paxlovid. This phenomenon is not unusual, and it suggests that regulators should modify the terms of the drug’s Emergency Use Authorization. When he headed the Food & Drug Administration, Dr. Frank Young used to admonish his minions that sometimes regulations need to...

The following op-ed has been authored by a non-clinician, it does not constitute medical advice. In an effort to boost access to the antiviral Paxlovid, the Food and Drug Administration (FDA) will now allow pharmacists to prescribe the medicine; the agency announced this last week, on July 6. Previously, patients seeking the drug, which has proven highly effective at preventing severe illness and death from COVID-19, needed a prescription from a doctor. That hurdle never really made sense. Paxlovid must be taken no more than five days...

By Henry I. Miller and Josh Bloom Decades ago, a case report (relating the experience with a single patient) was published which described how a person’s flu symptoms improved after a bowl of chicken soup, but then reappeared. The article was meant as a kind of parody of the old maxim that chicken soup is the best cure for a cold. Pediatricians occasionally see a similar phenomenon when children are treated with an antibiotic for an ear infection; they may then...

Did the Biden administration participate in closed-door meetings with foreign officials to deal away some of America's most valuable intellectual property? It appears so. According to a letter sent by six senators to U.S. Trade Ambassador Katherine Tai on May 10, the Biden administration negotiated a proposal with the European Union, India and South Africa to suspend IP protections for COVID-19 vaccines without consulting Congress like it's supposed to. The senators condemn her for negotiating behind their backs. They're right to be incensed. Ambassador Tai's...

Earlier this month, members of the World Trade Organization met to debate a proposal to waive intellectual property protections on COVID-19 vaccines. Supporters of the plan claim it's necessary to boost the supply of vaccines in developing countries and, in turn, vaccinate the world. But insufficient supply isn't holding up the global vaccination campaign. In fact, many developing countries have a surplus of vaccines. Consider South Africa, which is preparing to destroy its stockpile of expiring doses and terminate its mass vaccination program. Or take the Serum Institute of India, which shut...

By Henry I. Miller and Jeff Stier The two-years-plus of the COVID-19 pandemic should be a wakeup call that there is something very wrong – irreparable, even – at the chronically inept World Health Organization (WHO). Two recent transgressions show that the bureaucrats there are not getting any smarter. The first is almost inconceivable. Medicago, a Canadian company, developed a COVID-19 vaccine synthesized in the Nicotiniana plant, a relative of tobacco. In clinical testing, it showed efficacy against all variants studied prior to the emergence of Omicron of 71%, and for...

The Centers for Disease Control and Prevention just recommended that seniors get a second COVID-19 booster shot. But there are plenty of people over the age of 65 — one-third, according to the latest data — who have not yet gotten their first booster. Perhaps that's because it took until the omicron variant emerged last fall for the CDC to get behind booster shots for all adults. Or maybe it's because public health officials have been peddling confusing and contradictory messaging...

The federal public health emergency prompted by the COVID-19 pandemic is set to expire in mid-April. Some states have already let their own emergency declarations lapse. It's about time. COVID-19 is no longer the crisis it was back in 2020. Living in a permanent state of emergency is unsustainable. But that doesn't mean we should go back to the pre-pandemic status quo. Many of the reforms enacted during the state of emergency — especially those that liberalized the healthcare labor market — deserve to...

It ignores the risk of hazardous drug-drug interactions with the Pfizer pill. As someone who has closely followed and written extensively about the development of COVID-19 vaccines and drug treatments since the beginning of the pandemic, one pronouncement in President Joe Biden's State of the Union speech raised red flags: "We're also ready with antiviral treatments. If you get COVID-19, the Pfizer pill reduces your chances of ending up in the hospital by 90% ...

‘Test to Treat’ ignores the significant risk of drug interactions with the Pfizer pill. President Biden touted a new anti-Covid initiative in his State of the Union address Tuesday. “We’re also ready with antiviral treatments. If you get Covid-19, the Pfizer pill reduces your chances of ending up in the hospital by 90%,” he said. “And we’re launching the ‘Test to Treat’ initiative so people can get tested at a pharmacy, and if they’re positive, receive antiviral pills on the spot at no...

Good public health policy is welcome, even when long delayed. So we should cheer the Biden administration's announcement earlier this month that Covid-19 rapid-result antigen tests (RATs), which tell you in as little as 15 minutes whether you're infected, will be covered by private insurance. For uninsured Americans, the government would make 50 million free tests available, to be distributed through health clinics and other sites in rural and underserved communities. Assuming that they can detect the new Omicron variant along with...

Dr. Henry Miller and John Batchelor breakdown the latest developments of Omicron, a new variant of the coronavirus that was recently detected in South Africa. Miller talks about the latest information regarding infections, vaccine efficacy, and how countries are responding to the news. ...

This month, Delta Airlines began levying a $200 monthly surcharge on unvaccinated employees enrolled in the company’s health plan for the financial “risk” they are supposedly imposing on the company. The airliner is not alone. A major health-care system in Louisiana plans to do the same for unvaccinated spouses on its health plan next year. And a retailer in Utah announced last month that unvaccinated employees would have to pay extra for insurance. In other words, medical underwriting — the practice of...

Earlier this month, the Biden administration bought 10 million courses of Pfizer's new COVID-19 pill, Paxlovid. Thanks to the Food and Drug Administration, however, it may be months before anyone can take it, as the agency hasn't yet offered up a timetable for approving it. Its inaction will almost certainly result in scores of preventable deaths. In clinical trials, Paxlovid proved nearly 90% effective at preventing hospitalization and death. The results were so promising, Pfizer ended its trial of the drug early. It would have been...

An overwhelming consensus on any topic is very rare these days. But many Americans, whatever their political leanings, seem to feel that the policies, communications, and actions of the public health "experts" and politicians about the COVID-19 pandemic have been confusing, sometimes contradictory, and in some cases, inconsistent with the scientific evidence. Whether it was flip-flops on the effectiveness of masks, seemingly inane restrictions on certain activities, or baseless advocacy of ineffective drugs, the past 20 months have provided numerous reasons...

Dr. Henry Miller and John Batchelor talk about the coverage around COVID-19 surges in Europe and elsewhere and what that could mean for lockdowns and vaccinations. They discuss how the United Kingdom is handling a potential new surge including masking, vaccinations, and the arrival of new surges. Miller also talks about the various surges, especially related to the delta variant and the impact of long COVID symptoms. ...